-
公开(公告)号:ZA201103411B
公开(公告)日:2012-09-26
申请号:ZA201103411
申请日:2011-05-10
Applicant: VERTEX PHARMA
Inventor: CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KAY DAVID , O'DONNELL MICHAEL , KNEGTEL RONALD , MACCORMICK SOMHAIRLE , PINDER JOANNE , VIRANI ANISA , YOUNG STEPHEN , BINCH HAYLEY , CLEVELAND THOMAS , FANNING LEV T D , HURLEY DENNIS J , JOSHI PRAMOD , SHETH URVI , SILINA ALINA , REAPER PHILIP MICHAEL
IPC: C07D20060101 , A61K20060101 , A61P20060101
-
公开(公告)号:ES2998396T3
公开(公告)日:2025-02-20
申请号:ES20825397
申请日:2020-12-04
Applicant: VERTEX PHARMA
Inventor: DURRANT STEVEN , AHMAD NADIA , BECK ELIZABETH , CARVALHO MEIRELES LIDIO , CHUDYK EWA , ETXEBARRIA JARDI GORKA , GALAN BHAIRAVI , HADIDA RUAH SARA , HURLEY DENNIS , KNEGTEL RONALD , NEUBERT TIMOTHY , PINDER JOANNE , PONTILLO JOSEPH , PULLIN ROBERT , SCHMIDT YVONNE , SHAW DAVID , SKERRATT SARAH , STAMOS DEAN , THOMSON STEPHEN , VIRANI ANISA , WRAY CHRISTOPHER
IPC: C07D405/12 , A61K31/443 , A61P29/00 , C07D405/14
Abstract: Se proporcionan compuestos y sales farmacéuticamente aceptables de los mismos, útiles como inhibidores de los canales de sodio. También se proporcionan composiciones farmacéuticas que comprenden los compuestos o sales farmacéuticamente aceptables y métodos de uso de los compuestos, sales farmacéuticamente aceptables y composiciones farmacéuticas en el tratamiento de diversos trastornos, incluido el dolor. (Traducción automática con Google Translate, sin valor legal)
-
公开(公告)号:AU2009313198B2
公开(公告)日:2016-03-24
申请号:AU2009313198
申请日:2009-11-10
Applicant: VERTEX PHARMA
Inventor: CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KAY DAVID , O'DONNELL MICHAEL , KNEGTEL RONALD , MACCORMICK SOMHAIRLE , PINDER JOANNE , VIRANI ANISA , YOUNG STEPHEN , BINCH HAYLEY , CLEVELAND THOMAS , FANNING LEV T D , HURLEY DENNIS , JOSHI PRAMOD , SHETH URVI , SILINA ALINA , REAPER PHILIP MICHAEL
IPC: C07D401/04 , A61K31/4965 , A61P35/00 , C07D403/04 , C07D413/04
Abstract: The present disclosure relates to pyrazine compounds of formula (I) wherein L, n, R
-
公开(公告)号:NZ593316A
公开(公告)日:2013-06-28
申请号:NZ59331609
申请日:2009-11-10
Applicant: VERTEX PHARMA
Inventor: CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KAY DAVID , O DONNELL MICHAEL , KNEGTEL RONALD , MACCORMICK SOMHAIRLE , PINDER JOANNE , VIRANI ANISA , YOUNG STEPHEN , BINCH HAYLEY , CLEVELAND THOMAS , FANNING LEV T
IPC: C07D413/04 , A61K31/4965 , A61P35/00 , C07D401/04 , C07D403/04
Abstract: 593316 The present disclosure relates to pyrazine compounds of formula (Ia) wherein L, n, R1, and R2 are as described in the specification. These compounds are useful as inhibitors of ATR protein kinase. The disclosure also relates to pharmaceutically acceptable compositions comprising the compounds of the disclosure; methods of treating of various diseases, disorders, and conditions using the compounds of the disclosure; processes for preparing the compounds of the disclosure; intermediates for the preparation of the compounds of the disclosure; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. Compounds of the present disclosure include: 2-[5-Amino-6-[5-[4-(methylaminomethyl)phenyl]-1,3,4-oxadiazol-2-yl]pyrazin-2-yl]-N-ethyl-cyclopropanecarboxamide, 1-(4-(5-Amino-6-(5-( 4-((methylamino)methyl)phenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)piperidin-1-yl)propan-1-one, 1-(7-(5-Amino-6-(5-( 4-CCmethylamino)methy])phenyl)-I,3A-oxadiazol-2-y])pyrazin-2-y])-2,7-diazaspiro[4,4]nonan-2-y])propan-1-one, 1-{ 7-(5-Amino-6-(5-(4-((methylamino)methyllphenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-2,7-diazaspiro[4,4]nonan-2-yl} propan-1-one, 1-[S-amino-6-(S-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yI]-3 ,6-dihydro-2H-pyridine-4-carboxylic acid, 3-{ [1,2,4(triazolo[1,S-alpyridin-2-y])-S-(1-(ethylsulfony])-1,2,3,6-tetrahydropyridin-4-y])pyrazin-2-amine, 3-amino-N-(pyridin-2-yl)-6-(4-(thiophen-3-ylsulfonyl)piperazin-1-yl)pyrazine-2-carboxamide, 3-amino-6-(4-(phenylcarbonyl)piperazin-1-yl)-N-(pyridin-2-yl)pyrazine-2-carboxamide, 3-(1H-benzo[d]imidazol-2-yl)-5-(1-(thiophen-2-ylsulfonyl)-1,2,3,6-tetrahydropyridin-4-yl)pyrazin-2-amine and 4-(5-amino-6-(3H-imidazo[4,5-b]pyridin-2-yl)pyrazin-2-yl)-N,N-dimethyl-5,6-dihydropyridine-1(2H)-sulfonamide
-
公开(公告)号:HUE069128T2
公开(公告)日:2025-02-28
申请号:HUE20825397
申请日:2020-12-04
Applicant: VERTEX PHARMA
Inventor: DURRANT STEVEN , AHMAD NADIA , BECK ELIZABETH , CARVALHO MEIRELES LIDIO , CHUDYK EWA , ETXEBARRIA JARDI GORKA , GALAN BHAIRAVI , HADIDA RUAH SARA , HURLEY DENNIS , KNEGTEL RONALD , NEUBERT TIMOTHY , PINDER JOANNE , PONTILLO JOSEPH , PULLIN ROBERT , SCHMIDT YVONNE , SHAW DAVID , SKERRATT SARAH , STAMOS DEAN , THOMSON STEPHEN , VIRANI ANISA , WRAY CHRISTOPHER
IPC: C07D405/12 , A61P29/00 , C07D405/14
-
公开(公告)号:LT4069691T
公开(公告)日:2024-12-10
申请号:LTUS2020063290
申请日:2020-12-04
Applicant: VERTEX PHARMA
Inventor: DURRANT STEVEN , AHMAD NADIA , BECK ELIZABETH , CARVALHO MEIRELES LIDIO , CHUDYK EWA , ETXEBARRIA JARDI GORKA , GALAN BHAIRAVI , HADIDA RUAH SARA , HURLEY DENNIS , KNEGTEL RONALD , NEUBERT TIMOTHY , PINDER JOANNE , PONTILLO JOSEPH , PULLIN ROBERT , SCHMIDT YVONNE , SHAW DAVID , SKERRATT SARAH , STAMOS DEAN , THOMSON STEPHEN , VIRANI ANISA , WRAY CHRISTOPHER
IPC: C07D405/12 , A61K31/443 , A61P29/00 , C07D405/14
-
公开(公告)号:AU2016203414A1
公开(公告)日:2016-06-23
申请号:AU2016203414
申请日:2016-05-25
Applicant: VERTEX PHARMA
Inventor: CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KAY DAVID , O'DONNELL MICHAEL , KNEGTEI RONALD , MACCORMICK SOMHAIRLE , PINDER JOANNE , VIRANI ANISA , YOUNG STEPHEN , BINCH HAYLEY , CLEVELAND THOMAS , FANNING LEV , HURLEY DENNIS , JOSHI PRAMOD , SHETH URVI , SILINA ALINA
IPC: C07D401/04 , A61K31/4965 , A61P35/00 , C07D403/04 , C07D413/04
Abstract: Abstract The present invention relates to pyrazine compounds, pharmaceutical compositions comprising them, and methods for inhibiting ATR protein kinase for treating various diseases, disorders, and conditions including cancer, HIV, hepatitis, adenovirus and psoriasis. Additionally the invention discloses processes for preparing the compounds, intermediates used in the preparation, and methods of using the compounds in in vitro applications including the study of kinases in biological and pathological phenomena, the study of intracellular signal transduction pathways mediated by such kinases, and the comparative evaluation of new kinase inhibitors.
-
公开(公告)号:ECSP22052564A
公开(公告)日:2022-08-31
申请号:ECDI202252564
申请日:2022-07-05
Applicant: VERTEX PHARMA
Inventor: CHUDYK EWA , DURRANT STEVEN , WRAY CHRISTOPHER , CARVALHO MEIRELES LIDIO , KNEGTEL RONALD , AHMAD NADIA , PULLIN ROBERT , NEUBERT TIMOTHY , HADIDA RUAH SARA S , SCHMIDT YVONNE , BECK ELIZABETH , VIRANI ANISA , PONTILLO JOSEPH , STAMOS DEAN , SKERRATT SARAH , PINDER JOANNE , SHAW DAVID , ETXEBARRIA JARDI GORKA , THOMSON STEPHEN , HURLEY DENNIS , GALAN BHAIRAVI
IPC: C07D405/12
Abstract: Se proporcionan compuestos y sus sales farmac?uticamente aceptables, de utilidad como inhibidores de canales de sodio. Tambi?n se proporcionan composiciones farmac?uticas que comprenden los compuestos o sales farmac?uticamente aceptables y m?todos de uso de los compuestos, sales farmac?uticamente aceptables y composiciones farmac?uticas en el tratamiento de diversos trastornos, incluyendo el dolor.
-
公开(公告)号:ES2921576T3
公开(公告)日:2022-08-29
申请号:ES17205270
申请日:2009-12-18
Applicant: VERTEX PHARMA
Inventor: CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KAY DAVID , KNEGTEL RONALD , MACCORMICK SOMHAIRLE , MORTIMORE MICHAEL , O'DONNELL MICHAEL , PINDER JOANNE , RUTHERFORD ALISTAIR , VIRANI ANISA , YOUNG STEPHEN , REAPER PHILIP
IPC: C07D413/04 , A61K31/497 , A61P35/00 , C07D401/14 , C07D403/12 , C07D409/14 , C07D413/12 , C07D417/04 , C07D417/12 , C07D471/04
Abstract: La presente invención se relaciona con los compuestos de pirazina útiles como inhibidores de la proteína quinasa ATR. La invención también se relaciona con composiciones farmacéuticamente aceptables que comprenden los compuestos de esta invención; métodos de tratamiento de diversas enfermedades, trastornos y condiciones utilizando los compuestos de esta invención; procesos para preparar los compuestos de esta invención; intermedios para la preparación de los compuestos de esta invención; y métodos para usar los compuestos en aplicaciones in vitro, como el estudio de quinasas en fenómenos biológicos y patológicos; el estudio de las vías de transducción de señales intracelulares mediadas por tales quinasas; y la evaluación comparativa de nuevos inhibidores de la quinasa. Los compuestos de esta invención tienen la fórmula I: en donde las variables están como se definen en este documento. (Traducción automática con Google Translate, sin valor legal)
-
公开(公告)号:LT3354650T
公开(公告)日:2022-06-27
申请号:LT17205270
申请日:2009-12-18
Applicant: VERTEX PHARMA
Inventor: KAY DAVID , CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KNEGTEL RONALD , MACCORMICK SOMHAIRLE , MORTIMORE MICHAEL , O'DONNELL MICHAEL , PINDER JOANNE , RUTHERFORD ALISTAIR , VIRANI ANISA , YOUNG STEPHEN , REAPER PHILIP
IPC: C07D413/04 , A61K31/497 , A61P35/00 , C07D241/28 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D471/04
-
-
-
-
-
-
-
-
-